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Drug	of	interest	 n11	 n12	 n1+	
Without	drug	of	
interest	 n21	 n22	 n2+	







































































































































Addiction	 0	(0)	 0	(0)	 0	(0)	
Aggression	 667	(.60)	 596	(.54)	 746	(.93)	
Ataxia	 298	(.27)	 267	(.24)	 117	(.15)	
Confusional	state	 2902	(2.60)	 2733	(2.46)	 2057	(2.56)	
Delirium	 451	(.40)	 408	(.37)	 300	(.37)	
Delusion	 196	(.18)	 125	(.11)	 180	(.22)	
Dependence	 97	(.09)	 76	(.07)	 51	(.06)	
Disorientation	 840	(.75)	 824	(.74)	 625	(.78)	
Dissociation	 58	(.05)	 97	(.09)	 109	(.14)	
Dizziness	 5921	(5.31)	 7508	(6.76)	 6270	(7.81)	
Drug	abuse	 597	(.53)	 766	(.69)	 294	(.37)	
Drug	abuser	 134	(.12)	 33	(.03)	 33	(.04)	
Drug	addict	 0	(0)	 0	(0)	 0	(0)	
Drug	dependence	 614	(.55)	 704	(.63)	 248	(.31)	
Drug	diversion	 11	(.01)	 11	(.01)	 30	(.04)	




Elevated	mood	 6	(.01)	 20	(.02)	 20	(.02)	
Euphoric	mood	 190	(.17)	 597	(.54)	 159	(.20)	
Fall	 5290	(4.74)	 4381	(3.95)	 3212	(4.00)	
Feeling	abnormal	 3064	(2.75)	 4425	(3.99)	 4103	(5.11)	
Feeling	drunk	 242	(.22)	 670	(.60)	 177	(.22)	
Feeling	of	relaxation	 11	(.01)	 28	(.03)	 18	(.02)	
Gait	disturbance	 3090	(2.77)	 3443	(3.10)	 1667	(2.08)	









Hallucination,	mixed	 48	(.04)	 57	(.05)	 48	(.06)	




Intentional	overdose	 535	(.48)	 373	(.34)	 409	(.51)	
Intoxication	 0	(0)	 0	(0)	 0	(0)	




Off	label	use	 2325	(2.08)	 2118	(1.91)	 3058	(3.81)	





Psychosis	 0	(0)	 0	(0)	 0	(0)	
Acute	psychosis	 13	(.01)	 1	(<.01)	 7	(.01)	
Rebound	psychosis	 1	(<.01)	 0	(0)	 0	(0)	
Transient	psychosis	 0	(0)	 0	(0)	 0	(0)	
Somnolence	 3667	(3.29)	 5722	(5.15)	 2585	(3.22)	
Substance	abuse	 79	(.07)	 24	(.02)	 26	(.03)	




Substance	use	 7	(.01)	 5	(<.01)	 1	(<.01)	
Thinking	abnormal	 676	(.61)	 637	(.57)	 588	(.73)	
Tolerance	increased	 0	(0)	 0	(0)	 0	(0)	

































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Aggression	 90	(2.3)	 89	(2.6)	 40	(1.7)	
Ataxia	 49	(1.2)	 17	(0.5)	 4	(0.2)	
Confusional	state	 186	(4.7)	 119	(3.5)	 88	(3.8)	
Delirium	 57	(1.4)	 25	(0.7)	 25	(1.1)	
Delusion	 31	(0.8)	 24	(0.7)	 7	(0.3)	
Disorientation	 45	(1.1)	 41	(1.2)	 20	(0.9)	
Dissociation	 1	(<0.1)	 1	(<0.1)	 3	(0.1)	
Dizziness	 175	(4.4)	 158	(4.7)	 135	(5.9)	
Drug	abuser	 83	(2.1)	 18	(0.5)	 8	(0.3)	




Elevated	mood	 0	(0)	 4	(0.1)	 1	(<0.1)	
Euphoric	mood	 44	(1.1)	 95	(2.8)	 9	(0.4)	
Fall	 203	(5.2)	 142	(4.2)	 74	(3.2)	
Feeling	abnormal	 107	(2.7)	 160	(4.7)	 106	(4.6)	
Feeling	drunk	 7	(0.2)	 23	(0.7)	 3	(0.1)	
Feeling	of	relaxation	 2	(0.1)	 6	(0.2)	 0	(0)	
Gait	disturbance	 86	(2.2)	 92	(2.7)	 45	(2.0)	




Hallucination,	visual	 20	(0.5)	 15	(0.4)	 8	(0.3)	
Hallucination,	mixed	 3	(0.1)	 12	(0.4)	 1	(<0.1)	
Incoherent	 17	(0.4)	 6	(0.2)	 6	(0.3)	
Mood	altered	 18	(0.5)	 19	(0.6)	 17	(0.7)	
Off	label	use	 79	(2.0)	 104	(3.1)	 109	(4.7)	
Acute	psychosis	 0	(0)	 0	(0)	 1	(<0.1)	





Somnolence	 266	(6.8)	 278	(8.2)	 102	(4.4)	

























































AS-AE*Aggression	 2.35	(1.58,	3.48)	 2.83	(1.91,	4.20)	 REF	








AS-AE*Disorientation	 1.30	(.76,	2.22)	 1.32	(.73,	2.18)	 REF	
AS-AE*Dissociation	 --	 --	 --	
AS-AE*Dizziness	 1.15	(.91,	1.46)	 .85	(.67,	1.08)	 REF	
AS-AE*Drug	abuser	 --	 --	 --	







AS-AE*Elevated	mood	 --	 --	 --	
AS-AE*Euphoric	mood	 2.69	(1.25,	5.81)	 2.24	(1.11,	4.51)	 REF	

























AS-AE*Incoherence	 --	 --	 --	
AS-AE*Mood	altered	 1.05	(.53,	2.07)	 .98	(.50,	1.91)	 REF	
AS-AE*Off	label	use	 .77	(.57,	1.04)	 1.31	(1.00,	1.75)	 REF	
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